That population represents a huge potential market for GLP-1s
Most nausea resolves within 612 weeks and represents your body adjusting to improved metabolic control
Therapeutic strategies aimed at restoring the CTSBCTSL balance or promoting CTSL maturation may help mitigate pathological trypsin activation and reduce pancreatitis severity
High costs, unpleasant side effects, and underlying medical or psychiatric conditions play major roles in the dropouts
This advanced, dual-action GIP and GLP-1 receptor agonist is specifically designed for elevated metabolic control, offering a more comprehensive approach than traditional single-pathway therapies
Company Profile Shimu group was founded in 2001, located in Shijiazhuang high-tech industrial zone, including Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd, Hebei Tianqiong International Trade Co., Ltd, Hebei Huamu Tianhe Biological technology Co., Ltd, three pillar industries